Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial
Agnihotram V Ramanakumar, Paulo Naud, Cecilia M Roteli-Martins, Newton S de Carvalho, Paola C de Borba, Julio C Teixeira, Mark Blatter, Anna-Barbara Moscicki, Diane M Harper, Barbara Romanowski, Stephen K Tyring, Brian Ramjattan, Anne Schuind, Gary Dubin, Eduardo L Franco
BMJ Open Aug 2016, 6 (8) e011371; DOI: 10.1136/bmjopen-2016-011371